Does aTR blockade reduce IFN-gamma production in lymphocytes in vivo and in vitro?
AT(1)R blockers may have a clinically relevant immunomodulatory role by blocking IFN-gamma production in T cells.
Early posttransplant elevation of proinflammatory mediators is associated with alloimmunity and chronic human lung allograft rejection.